Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionClose Asset Management Ltd
Latest Disclosed Ownership268 shares
Latest Disclosed Value $ 35
Close Asset Management Ltd ownership in NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - Close Asset Management Ltd filed a 13F-HR form disclosing ownership of 268 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $35 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 268 shares of Neurocrine Biosciences, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0009
2026-02-10 2025-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0008
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0008
2025-08-12 2025-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0010
2025-05-06 2025-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0009
2025-01-28 2024-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0010
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0010
2024-08-07 2024-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0013
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0014
2024-02-08 2023-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0015
2023-10-11 2023-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0015
2023-07-26 2023-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0012
2023-04-19 2023-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 0.0013
2023-01-27 2022-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 0 -100.00 0.0017
2022-10-26 2022-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 28 7.69 0.0016
2022-07-29 2022-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 13.04 0.0012
2022-04-27 2022-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 23 0.00 0.0008
2022-01-27 2021-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 23 -11.54 0.0008
2021-11-04 2021-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 0.00 0.0013
2021-07-27 2021-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 0.00 0.0012
2021-05-07 2021-03-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 0.00 0.0014
2021-01-22 2020-12-31 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 0.00 0.0020
2020-10-30 2020-09-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 26 -21.21 0.0018
2020-07-28 2020-06-30 13F NEUROCRINE BIOSCIENCES INC COM USD0.001 COM 64125C109 268 0 0.00 33 43.48 0.0025
2020-05-05 2020-03-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 0 0.00 23 -20.69 0.0020
2020-01-22 2019-12-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 0 0.00 29 20.83 0.0023
2019-11-06 2019-09-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 0 0.00 24 4.35 0.0021
2019-08-01 2019-06-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 0 0.00 23 -4.17 0.0018
2019-05-10 2019-03-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 -1,039,174 -99.97 24 -99.98 0.0020
2019-01-28 2018-12-31 13F MICROSOFT CORP COM USD0.00000625 COM 64125C109 1,039,442 1,039,174 387,751.49 105,675 320,127.27 11.6961
2018-11-09 2018-09-30 13F/A-2 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 268 -100 -27.17 33 13.79 0.0027
2018-11-07 2018-09-30 13F/A-1 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 100 29 0.0025
2018-11-02 2018-09-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 29
2018-08-03 2018-06-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 29 0.00 0.0025
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 29 0.00 0.0023
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 29 26.09 0.0026
2018-02-13 2017-09-30 13F/A-1 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 23 35.29 0.0023
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 23
2018-02-13 2017-06-30 13F/A-1 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 17 6.25 0.0019
2017-11-14 2017-06-30 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 17
2018-02-13 2017-03-31 13F/A-1 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 0.00 16 14.29 0.0017
2017-11-14 2017-03-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 0 16
2018-02-13 2016-12-31 13F/A-1 NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 368 14 0.0021
2017-11-14 2016-12-31 13F NEUROCRINE BIOSCIE COM USD0.001 COM 64125C109 368 14
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.